STR Biotechnologies is a leading manufacturer specializing in regenerative medicine and biotechnology solutions, operating from its state-of-the-art production facility located in the Çorum Organized Industrial Zone, Türkiye. Established with government support, the facility encompasses 6,000 m² of open area and 2,200 m² of closed production space, enabling the company to manufacture high-quality medical devices and consumables in accordance with international standards.

​

Our extensive product portfolio addresses various applications within regenerative medicine, including PRP (Platelet-Rich Plasma), CGF (Concentrated Growth Factors), PRF (Platelet-Rich Fibrin), SVF (Stromal Vascular Fraction), bone marrow-derived cellular therapies, cytokine-based treatments, and ozone therapy systems.

​

Under the HighCell and Unique PRP brands, STR Biotechnologies offers advanced PRP systems designed for use in aesthetic medicine, orthopedics, sports medicine, and hair restoration applications. Through the GrowthCell brand, we provide CGF preparation kits, while our LABFUGE centrifuge systems support PRP, CGF, PRF, and SVF preparation protocols. For dental applications, our PRF Box and PRF solutions facilitate efficient platelet-rich fibrin preparation.

​

In the field of cellular therapies, STEMMEX Bone Marrow Concentration Kits and LIPOSTEM SVF Kits provide innovative solutions for regenerative applications. Additionally, our STRAKIN and INTRAKIN product lines offer cytokine- and interleukin-rich plasma preparation systems to support advanced therapeutic approaches. STRozone ozone therapy bottles have been developed to ensure safe and effective ozone applications. Furthermore, our portfolio is strengthened by Renewa Capilla hair regeneration solutions, ExoPrime and ReNova exosome technologies, and bioregenerative products such as CHondroGrid and HP Cell Vitaran J.

​

As of 2026, STR Biotechnologies operates with an MDR CE-certified manufacturing infrastructure and quality management system, prioritizing patient safety, product efficacy, and full regulatory compliance.

​

By integrating extensive expertise in manufacturing and quality assurance with valuable feedback from healthcare professionals and ongoing scientific advancements, STR Biotechnologies continuously improves its products and processes. Guided by the principles of innovation, continuous improvement, and customer satisfaction, we remain committed to delivering reliable, cutting-edge solutions that advance the future of regenerative medicine.